Home > Insider Trading > Filing (0001209191-11-033964)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1046336	S Kenneth Boger	C/O Vertex Pharmaceuticals Incorporated 130 Waverly St Cambridge MA 02176	Svp & General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-06-08	7,333	$18.75	120,332	No	4	M	Direct
Common Stock	Disposition	2011-06-08	7,333	$53.38	112,999	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2011-06-08	7,333	$0.00	7,333	$18.75

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
73,335		2011-09-23	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,021	Indirect	401(k)
Common Stock	174,167	Indirect	Trustee of Trusts

Footnotes

Transaction made pursuant to Mr. Boger's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $53.38 (range $52.98 to $54.12).
Mr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Kenneth S. Boger is the trustee for trusts established for the benefit of the three adult children of Joshua S. Boger (a director of the issuer).
Fully vested.